Joshua Korzenik, MD
Assistant Professor of Medicine
Harvard Medical School
Co-Director, Crohn's and Colitis Center
Director, Translational Research
| Address: | Massachusetts General Hospital MGH Digestive Health Center 100 Charles River Plaza, 9th Floor Boston, MA 02114 |
| Patient Appointments: | (617) 726-0267 |
| Academic Phone: | (617) 724-6113 |
| Fax: | (617) 726-3080 |
| E-Mail: | jkorzenik@partners.org |
| Clinical Background: | |
| MD Degree: | Albert Einstein College of Medicine, 1983-1987 |
| Residency: | Beth Israel Hospital, 1987-1990 |
| Fellowship: | Gastroenterology, Yale School of Medicine 1991-1994 |
| Board Certifications: | Internal Medicine, 1993 Gastroenterology; Hepatology, 1993 |
| Clinical Interests: | Ulcerative Colitis Crohn's Disease Hereditary Hemorrhagic Telangiectasia |
| Research Interests: | Ulcerative Colitis Crohn's Disease |
Publications:
- Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ. Sargramostim for active Crohn's disease. N Engl J Med. 2005 May 26;352(21):2193-201.
- Korzenik JR. Dieckgraefe BK. Crohn's Disease: An Immunodeficiency disease: A Hypothesis Suggesting Possible Early Events in the Pathogenesis of Crohn's Disease. Digestive Disease and Sciences 2000;45:1121-1129.
- Dieckgraefe, BK, Korzenik, J., Husain, A., Dieruf, L. and the North American GSD study group. Association of Glycogen Storage Disease 1b and Crohn's disease: Results of a North American Survey. European Journal of Pediatrics161 Suppl 1:S88-92, 2002.
- Dieckgraefe, BK, and Korzenik, J. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF). Lancet. 2002; 360:1478-80.
